Lancet Respiratory Medicine publishes Phase 2 data of Medigen Covid-19 vaccine
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals and is part of its Digital Access to Care Initiative
The company to receive upfront and milestone payments, in addition to royalties
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
Subscribe To Our Newsletter & Stay Updated